<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a multicenter analysis, the effect of low-dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> (Ara-C)(10 mg/ m2q 12 h subcutaneously for a minimum of 15 days) has been assessed in 13 patients with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (10 myeloid-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-, 3 lymphocytic-ALL-) and 7 patients with <z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">dysmyelopoietic syndromes</z:e> (<z:chebi fb="0" ids="888">DMPS</z:chebi>), conditions classified as <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with an excess of blasts ( <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> ) </plain></SENT>
<SENT sid="1" pm="."><plain>Seven patients suffering from <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> and 1 with <z:chebi fb="0" ids="888">DMPS</z:chebi> in blastic transformation displayed a <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> of more than 10 X 10(9)/1 </plain></SENT>
<SENT sid="2" pm="."><plain>Three out of 7 DMPS, 1 out of 10 AML achieved a complete remission, 1 out of 3 ALL-patients reached a partial remission twice </plain></SENT>
<SENT sid="3" pm="."><plain>Seven patients showed a blast clearing in the bone marrow and peripheral blood, in another 7 instances examination of the bone marrow was not performed after therapy because of early <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The majority of patients were in their late phase of disease and refractory to conventional chemotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>Only 5 patients had no pretreatment at first presentation before low-dose Ara-C was initiated </plain></SENT>
<SENT sid="6" pm="."><plain>At least for the <z:chebi fb="0" ids="888">DMPS</z:chebi>-group, this therapeutic approach seems to be of some benefit </plain></SENT>
</text></document>